0001104659-24-054953.txt : 20240430 0001104659-24-054953.hdr.sgml : 20240430 20240430161738 ACCESSION NUMBER: 0001104659-24-054953 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240429 FILED AS OF DATE: 20240430 DATE AS OF CHANGE: 20240430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EBSWORTH DAVID R CENTRAL INDEX KEY: 0001207107 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38067 FILM NUMBER: 24897514 MAIL ADDRESS: STREET 1: C/O CURAGEN CORP STREET 2: 555 LONG WHARF DR. 11TH FL. CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verona Pharma plc CENTRAL INDEX KEY: 0001657312 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE BUSINESS PHONE: 011-44-0-2032834200 MAIL ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE 4 1 tm2412993-8_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-04-29 0 0001657312 Verona Pharma plc VRNA 0001207107 EBSWORTH DAVID R 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE UNITED KINGDOM 1 0 0 0 0 Share Options (Right to Buy) 1.9338 2024-04-29 4 A 0 240000 0 A 2034-04-28 Ordinary Shares 240000 240000 D The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer. The option vests and becomes exercisable as to 25% on each of July 29, 2024, October 29, 2024, January 29, 2025 and April 29, 2025. /s/ Claire Poll, Attorney-in-fact for David R. Ebsworth 2024-04-30